Rockville, United States , 2022-Apr-19 — /EPR Network/ — The study on the benign prostatic hyperplasia (BPH) treatment market is an exclusive report published by [read full press release…]
Northbrook, IL, USA, 2021-Dec-14 — /EPR Network/ — According to the new market research report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), [read full press release…]
Northbrook, IL, USA, 2021-Nov-29 — /EPR Network/ — According to the new market research report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), [read full press release…]
The study on the benign prostatic hyperplasia (BPH) treatment market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that [read full press release…]
Benign Prostatic Hyperplasia Treatment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data [read full press release…]
Pune, India, 2021-Jul-29 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
Pune, India, 2021-May-28 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
Pune, India, 2021-May-19 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
Pune, India, 2021-Apr-30 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
Pune, India, 2021-Apr-26 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
Pune, India, 2021-Apr-06 — /EPR Network/ — The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 [read full press release…]
The report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) [read full press release…]
The report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) [read full press release…]
The report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) [read full press release…]
The report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User [read full press release…]
